Sign in
HILS Stock Price, Chart, Stats & News
Hillstream BioPharma, Inc.
Save
Hillstream BioPharma, Inc. (HILS) does not currently pay a dividend.
4.17M
Market cap
–
Current P/E
–
Forward P/E
HILS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -0.17% |
ROA | -153.92% |
ROE | -675.73% |
D/E | – |
Interest coverage ratio | 2160.42x |
HILS valuation
P/E | – |
P/S | – |
P/B | 0.24x |
P/CF | -0.14x |
P/FCF | -0.39x |
P/OCF | -0.14x |
PEG | -0.01x |
EV multiple | -0.99x |
About
Hillstream BioPharma, Inc. is a pre-clinical stage biotechnology firm committed to creating groundbreaking therapeutic options. Its core mission is to exploit ferroptosis, an anti-cancer pathway that initiates iron-mediated cell death (IMCD), specifically to address cancers that are resistant to conventional treatments. The company's developmental pipeline features several key candidates: HSB-1216: An IMCD inducer currently under development for solid tumor indications.
Similar securities
Based on sector and market capitalization
Report issue